Alyeska Investment Group, L.P. Geron Corp Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Geron Corp stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 769,231 shares of GERN stock, worth $1.97 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
769,231Holding current value
$1.97 Million% of portfolio
0.03%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GERN
# of Institutions
304Shares Held
460MCall Options Held
1.44MPut Options Held
687K-
Black Rock Inc. New York, NY46.6MShares$119 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA33.5MShares$85.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA30MShares$76.8 Million1.72% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$69.7 Million18.81% of portfolio
-
State Street Corp Boston, MA27.2MShares$69.5 Million0.0% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $967M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...